Industry News

      ACTICOR BIOTECH: Presentation of Positive Results From the ACTIMIS Phase 1b/2a Study in Stroke at ESOC 2022

      PARIS--(BUSINESS WIRE)--Regulatory News: ACTICOR BIOTECH (ISIN : FR0014005OJ5 – ALACT), a clinical-stage biotechnology company developing an innovative drug for the treatment of cardiovascular emergencies, announces...

      Wellness Expert Lindora Launches Hormone Replacement Therapy

      IRVINE, Calif.--(BUSINESS WIRE)--In a move to further expand valuable services to its patient base, Lindora Wellness, Inc. announced today that it will begin to...

      Sygnature Discovery to Deploy Iktos’s AI for Drug Design Software Makya™

      PARIS & NOTTINGHAM, England--(BUSINESS WIRE)--Iktos, a company specialized in Artificial Intelligence (AI) for new drug design and Sygnature Discovery, a leading integrated drug discovery...

      Recent Articles

      Get a free copy of "Cracking the Generics Code"

      Looks like you are using an ad-blocking browser extension. We request you to whitelist our website on the ad-blocking extension and refresh your browser to view the content.